These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 6196075

  • 1. Radioimmunodetection of cancer: problems and potential.
    Rankin EM, McVie JG.
    Br Med J (Clin Res Ed); 1983 Nov 12; 287(6403):1402-4. PubMed ID: 6196075
    [No Abstract] [Full Text] [Related]

  • 2. Radioimmunodetection of primary and secondary germ cell tumors.
    Van Cangh PJ, Ferrant A, Ninane J, Humblet Y, Deckers C.
    Prog Clin Biol Res; 1985 Nov 12; 203():127-38. PubMed ID: 2421326
    [No Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of neoplasms with radionuclide-labeled antibodies.
    DeLand FH, Goldenberg DM.
    Semin Nucl Med; 1985 Jan 12; 15(1):2-11. PubMed ID: 2580353
    [Abstract] [Full Text] [Related]

  • 4. Tumor markers in testis tumors.
    Kansu E.
    Turk J Pediatr; 1984 Jan 12; 26(1-4):277-83. PubMed ID: 6085661
    [No Abstract] [Full Text] [Related]

  • 5. Tumor markers: how useful are they?
    McIntire KR.
    Hosp Pract (Off Ed); 1984 Dec 12; 19(12):55-68. PubMed ID: 6209292
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
    Wagener C, Breuer H.
    J Clin Chem Clin Biochem; 1977 Oct 12; 15(10):529-43. PubMed ID: 72783
    [No Abstract] [Full Text] [Related]

  • 7. Potential applications of monoclonal antibodies in cancer diagnosis and therapy.
    Chu TM.
    Cancer Invest; 1985 Oct 12; 3(6):565-84. PubMed ID: 2417671
    [No Abstract] [Full Text] [Related]

  • 8. The value of tumor markers in cancer of the ovary.
    Cantarow WD, Stolbach LL, Bhattacharya M, Chatterjee SK, Barlow JJ.
    Int J Radiat Oncol Biol Phys; 1981 Aug 12; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of radiolabeled antibodies for localization of neoplasms. The state of the art.
    Wolf P, Reid D.
    Arch Intern Med; 1981 Jul 12; 141(8):1067-70. PubMed ID: 6166259
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S, Miyake H.
    Kitasato Arch Exp Med; 1988 Sep 12; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract] [Full Text] [Related]

  • 14. Tumour markers. Their role in clinical medicine.
    Dearnaley DP, Coombes RC.
    Practitioner; 1981 Jun 12; 225(1356):839-49. PubMed ID: 6170974
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor markers in the ovarian carcinoma.
    Margariti PA, Benedetti Panici P, Villani L, Di Roberto P, Maiorca A, Sacco F, Bompiani A.
    Eur J Gynaecol Oncol; 1980 May 12; 1(2):77-9. PubMed ID: 6174341
    [No Abstract] [Full Text] [Related]

  • 17. Detection of tumours using radiolabelled antibodies.
    Bradwell AR, Fairweather DS, Dykes PW.
    Radiography; 1983 Jan 12; 49(577):5-12. PubMed ID: 6191357
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Significance of tumor markers in clinical oncology].
    Gericke D, Drahovsky D.
    Med Klin; 1979 May 11; 74(19):701-9. PubMed ID: 88005
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.